Peptide PilotPeptide Pilot

mg ↔ units

Semaglutide mg to units converter

Set your Semaglutide vial concentration once, then flip in either direction between milligrams and U-100 syringe units.

Download Peptide PilotiPhone · Free to download

mg

0.250

units

10.0

mL

0.100

Concentration: 2.50 mg/mL (assumes a U-100 insulin syringe).

Semaglutide is a once-a-week injection people use to lose weight and steady blood sugar. It mimics a gut hormone called GLP-1, which makes you feel full sooner and slows how fast your stomach empties. In the STEP-1 trial, adults without diabetes lost about 14.9% of their body weight over 68 weeks on the highest dose. This page covers the reconstitution math and how people log each weekly dose.

How the Semaglutide mg ↔ units converter works

This converter is a two-way bridge between dose mass (mg or mcg) and the unit count you actually draw on an insulin syringe. Once you set the Semaglutide concentration of your current vial, you can type any mg value and read the units back, or type any unit count and read the mg back. It is the same math as the dose calculator, but bidirectional, which matters when you are checking a dose someone else recorded in units against a protocol written in mg.

The formula in both directions: mg = mL × concentration mg/mL, and units = mL × 100 on a U-100 syringe. With a 2.5 mg/mL Semaglutide solution, 0.25 mg comes out to 10 units, and 10 units comes out to 0.25 mg. The converter handles the unit flip automatically so you never multiply or divide in your head while holding a syringe.

Concentration is the input that changes the answer most. A 5 mg vial diluted with 1 mL is twice as concentrated as the same vial diluted with 2 mL, which means the same dose draws half as many units. That is the single biggest source of converter confusion: a remembered unit count from an old vial does not transfer to a new vial reconstituted with different water volume.

Use the converter whenever a protocol or research note is written in one unit and your syringe is labeled in the other. It is also useful for sanity-checking that a planned titration step lands at a unit count you can read accurately on the syringe — under five units gets hard to read, over fifty starts crowding into the back third of a 1 mL syringe.

Why this matters for Semaglutide

Semaglutide is a synthetic peptide that mimics glucagon-like peptide-1, a hormone the gut releases after eating. It became one of the most widely used peptides in the world after pharmaceutical formulations — sold under brand names like Ozempic and Wegovy — gained regulatory approval for blood-sugar management and weight management.

In a research and personal-logging context, semaglutide is almost always supplied as a lyophilized white powder inside a small glass vial, rated in milligrams of active peptide. The vial has to be reconstituted with bacteriostatic water before any volume can be drawn into a syringe. Common vial sizes seen in the research market range from 2 mg up to 10 mg or larger.

Because semaglutide is long-acting — its half-life is roughly a week — it is typically logged on a weekly cadence. That single property shapes everything about how the peptide is dosed, how often a vial is opened, and how vial duration is calculated for refill planning.

Semaglutide mechanism in plain English

GLP-1 agonists bind to receptors in the pancreas and the brain. Activating the pancreatic receptor influences insulin and glucagon release in response to glucose; activating the central receptor influences appetite and gastric emptying. Semaglutide is engineered to resist enzymatic breakdown, which is what gives it its long half-life relative to native GLP-1.

Researchers and individuals tracking semaglutide are usually looking at weekly weight, hunger ratings, blood sugar readings, and side-effect notes alongside the dose log itself. Pairing those metrics with the dose history is how patterns become visible — for example, whether a dose change correlated with a change in hunger ratings the following week.

The ~7-day half-life mathematically dictates how Semaglutide accumulates in the body to reach a steady-state concentration. After the first weekly dose, approximately 50% of the peptide remains after seven days, at which point the second dose is administered. This new dose adds to the remaining concentration from the first. This stacking process continues with each subsequent weekly administration, with the total amount of the peptide present in the body incrementally increasing. After approximately four to five half-lives, or four to five weeks, the amount being eliminated over the week becomes roughly equal to the amount being added, establishing a concentration plateau known as steady state. This dynamic explains why logged observations during the first month may differ from those documented once this plateau is reached.

Tracking Semaglutide unit counts

Tracking semaglutide well means linking each dose log entry to the specific vial it came from, so the unit count on the syringe always reflects that vial's actual concentration. When a vial is finished and a new one is set up, the new vial's reconstitution numbers replace the old ones automatically — no muscle memory carries over from the prior vial.

Pairing the dose log with weekly weight and weekly hunger ratings turns a list of injections into a real signal. Peptide Pilot was built around exactly this pattern: log the dose, log the metric, and let the app surface the trend over weeks rather than asking you to scroll through note entries.

For sophisticated personal tracking of a multi-step Semaglutide protocol, logging should go beyond simple weekly dose entries. The most effective method is to create a distinct milestone entry in the log for each titration event. This means specifically documenting, for instance, 'Titration to 0.5 mg' on the exact date it occurs. This approach structures the entire data set, allowing a user to later filter and analyze all subsequent observations—such as body weight, food intake, or side effects—based on the active dose period. This turns a simple timeline into a structured database, where one can isolate and observe the body's response during the '0.25 mg phase' versus the '0.5 mg phase,' providing clarity that a flat log cannot.

Common Semaglutide conversion mistakes

  • Switching to a new vial of the same peptide and reusing the old unit count without re-running the calculation against the new vial's diluent volume.
  • Storing reconstituted semaglutide at room temperature for hours before refrigerating, especially after a travel day.
  • Dosing twice in the same week after forgetting whether the previous injection was Sunday or Monday — almost always a logging-gap problem, not a math problem.
  • Reading 0.25 mg as 25 units on the syringe regardless of vial concentration. The unit count is not fixed — it depends on the diluent volume.
  • Increasing the dose without writing down the date, then losing track of when the escalation began.
  • Confusing the multi-dose pen formulation marketed under brand names with the lyophilized powder vials common in the research market — they are not interchangeable preparations.
  • Failing to account for the cumulative effect of a long half-life, where each new weekly dose builds upon the concentration remaining from previous weeks.
  • Neglecting to log the precise calendar date of a dose titration, which makes it impossible to accurately correlate tracked metrics with the corresponding dose level.
  • Incorrectly calculating the new injection volume (mL or units) required after a dose increase, often by assuming the volume stays the same as the mass changes.

Frequently asked questions about Semaglutide mg ↔ units

How is semaglutide reconstituted?
By adding a measured volume of bacteriostatic water to the lyophilized vial through the rubber stopper, then swirling — not shaking — until the powder fully dissolves into a clear solution. The exact diluent volume is up to the user; common choices for a 5 mg vial are 1, 2, or 3 mL.
How many units of semaglutide are in 0.25 mg?
It depends on the concentration of your vial. On a 5 mg vial reconstituted with 2 mL of bacteriostatic water, 0.25 mg is exactly 10 units on a U-100 insulin syringe. On a 5 mg vial reconstituted with 1 mL, the same dose is 5 units.
Why is semaglutide dosed weekly?
Because its half-life is approximately one week, which keeps blood plasma levels stable on a once-weekly injection schedule. That cadence is part of why semaglutide became attractive relative to earlier GLP-1 peptides that required daily dosing.
How long does a 5 mg vial of semaglutide last?
At a 0.25 mg weekly dose, a 5 mg vial provides 20 doses, which is 20 weeks of supply. The vial duration calculator will run the math for any combination of vial size, dose, and frequency.
Does semaglutide need to be refrigerated?
The lyophilized powder is generally stored refrigerated, and the reconstituted solution is kept refrigerated and used within roughly four to six weeks. Writing the reconstitution date on the vial helps prevent using a long-opened vial past its useful life.
Can semaglutide be split across multiple injections per week?
Some users do split a weekly dose into two smaller injections to smooth side effects, while others do not. The math still works the same way — the calculator handles any frequency you give it. Whether to split a dose is a decision to discuss with a healthcare professional, not something a calculator answers.
What is the difference between Ozempic and lyophilized semaglutide vials?
Ozempic and Wegovy are pharmaceutical formulations supplied in pre-filled multi-dose pens. Lyophilized vials of semaglutide that appear in the research market are powder-based and require reconstitution. The active peptide is the same molecule, but the products are not interchangeable preparations and should be tracked separately.
Why does the app store every semaglutide vial separately?
Because each vial may have been reconstituted with a different volume of bacteriostatic water, producing a different concentration. Tying every dose entry to its specific vial means the unit count on the syringe is always derived from that vial's real numbers, not from a remembered ratio that may no longer apply.
Why do tracked observations with Semaglutide often change during the first month?
Observations may change because of the peptide's long half-life of approximately seven days. Each weekly dose builds on top of what remains from previous weeks, causing a gradual increase in the body's total concentration. This accumulation phase continues until a 'steady state' is reached after about 4-5 weeks, at which point the peptide's level is more stable. The initial period reflects this build-up phase.
My research protocol involves increasing the dose every 4 weeks. Why is it critical to log these dates?
Logging the exact date of each dose increase, or titration, is the single most important action for data analysis. Without these dates, you cannot later determine which of your logged metrics or notes correspond to which dose. Your entire log for the first month at one dose would be mixed with data from the second month at a higher dose, making it impossible to observe dose-dependent patterns.
If my dose doubles from 0.25 mg to 0.5 mg, do I draw the same number of units on my syringe?
No, the volume drawn or unit count must also double. The concentration of your reconstituted vial is constant, so to double the dose mass, you must double the liquid volume. Following the standard numeric example, a 0.25 mg dose is 10 units (0.1 mL). Therefore, a 0.5 mg dose would require you to draw 20 units (0.2 mL) from the same vial to deliver the correct mass.

Related on Peptide Pilot

Save your Semaglutide vial in the app

Download on the App Store
Get the App